Immunotherapy for diffuse gastric cancer: challenges and new avenues Summary Immunotherapy offers promise for treating diffuse gastric cancer (DGC), a particularly aggressive subtype with limited therapeutic options. However, DGC presents unique challenges, including low immunogenicity Read More
Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study Summary A Turkish Oncology Group study investigated the prognostic and Read More
DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B Summary The DisTinGuish trial Part B investigated the combination of DKN-01, a DKK1 inhibitor, and tislelizumab, an anti-PD-1 antibody, as Read More
Challenges and perspectives of CAR-T cell therapy in solid tumours: insights from gastric cancer Summary CAR-T cell therapy, while effective in hematological malignancies, faces significant challenges in solid tumors like gastric cancer. These hurdles include Read More
Top 10 Cancers difficult to cure Contents The top ten cancers that are difficult to cure, first of all pancreatic cancer, also include cholangiocarcinoma, liver cancer, gastric cancer, breast cancer and cervical cancer, and other cancers Read More
1 Million+ Views and Counting..!
It has been 7 years since it was launched in late July 2018, and it is moving forward. Appreciate all the respected visitors! Please share this site with your friends to push science forward and improve human health.
